The clinical use of tumor necrosis factor α (TNF) as an anticancer drug is limited to local treatments because of its dose-limiting systemic toxicity. We show here that murine TNF fused with CNGRC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results